These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9486247)

  • 1. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
    Wyatt TA; Naftilan AJ; Francis SH; Corbin JD
    Am J Physiol; 1998 Feb; 274(2):H448-55. PubMed ID: 9486247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
    Corbin JD; Turko IV; Beasley A; Francis SH
    Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS
    Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M; Rybalkin SD; Rybalkina IG; Feil R; Wolfsgruber W; Hofmann F; Beavo JA
    J Neurosci; 2003 Jul; 23(16):6452-9. PubMed ID: 12878685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
    Kim D; Aizawa T; Wei H; Pi X; Rybalkin SD; Berk BC; Yan C
    J Mol Cell Cardiol; 2005 Jan; 38(1):175-84. PubMed ID: 15623434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
    Rybalkin SD; Rybalkina IG; Feil R; Hofmann F; Beavo JA
    J Biol Chem; 2002 Feb; 277(5):3310-7. PubMed ID: 11723116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells.
    Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ
    Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP; Safai M; Gardner DG; Humphreys MH
    Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
    Gopal VK; Francis SH; Corbin JD
    Eur J Biochem; 2001 Jun; 268(11):3304-12. PubMed ID: 11389733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation.
    Turko IV; Francis SH; Corbin JD
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):505-10. PubMed ID: 9445376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
    Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
    Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclic GMP in atrial natriuretic factor stimulation of Na+,K+,Cl- cotransport in vascular smooth muscle cells.
    O'Donnell ME; Owen NE
    J Biol Chem; 1986 Nov; 261(33):15461-6. PubMed ID: 2430959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
    Kotera J; Grimes KA; Corbin JD; Francis SH
    Biochem J; 2003 Jun; 372(Pt 2):419-26. PubMed ID: 12617722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
    Rybalkin SD; Rybalkina IG; Shimizu-Albergine M; Tang XB; Beavo JA
    EMBO J; 2003 Feb; 22(3):469-78. PubMed ID: 12554648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational conversion of PDE5 by incubation with sildenafil or metal ion is accompanied by stimulation of allosteric cGMP binding.
    Corbin JD; Francis SH
    Cell Signal; 2011 Oct; 23(10):1578-83. PubMed ID: 21620965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5).
    Kotera J; Fujishige K; Michibata H; Yuasa K; Kubo A; Nakamura Y; Omori K
    Biochem Pharmacol; 2000 Nov; 60(9):1333-41. PubMed ID: 11008127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells.
    Ning H; Xin ZC; Lin G; Banie L; Lue TF; Lin CS
    Urology; 2006 Dec; 68(6):1350-4. PubMed ID: 17169663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.